First Time Loading...
A

Alliance Pharma PLC
LSE:APH

Watchlist Manager
Alliance Pharma PLC
LSE:APH
Watchlist
Price: 33.1 GBX -1.78% Market Closed
Updated: May 5, 2024

Alliance Pharma PLC
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alliance Pharma PLC
Net Income (Common) Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
A
Alliance Pharma PLC
LSE:APH
Net Income (Common)
-£7.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Net Income (Common)
£4.9B
CAGR 3-Years
-5%
CAGR 5-Years
6%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Net Income (Common)
$6B
CAGR 3-Years
23%
CAGR 5-Years
23%
CAGR 10-Years
9%
Indivior PLC
LSE:INDV
Net Income (Common)
$2m
CAGR 3-Years
N/A
CAGR 5-Years
-63%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Net Income (Common)
$190m
CAGR 3-Years
-24%
CAGR 5-Years
-8%
CAGR 10-Years
-1%
Dechra Pharmaceuticals PLC
LSE:DPH
Net Income (Common)
-£27.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Alliance Pharma PLC's Net Income (Common)?
Net Income (Common)
-7.1m GBP

Based on the financial report for Jun 30, 2023, Alliance Pharma PLC's Net Income (Common) amounts to -7.1m GBP.